Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

MGTS reported for 6 months by IFRS

8/23/23 MGTS

Atom electric cars will be assembled at the Moskvich plant

8/23/23 KMAZ

APRIORI Association proposes to close the entire video game market to VK

8/23/23 VKCO

Moscow Exchange reported for 6 months of 2023

8/23/23 MOEX

MMK expects record shipment of products to the Russian market

8/23/23 MAGN

Draft decree on the exchange of frozen assets has been prepared

8/23/23 MOEX

MMK has found an equipment supplier for the new blast furnace

8/23/23 MAGN

Driving school Svetofor reported for 6 months of 2023 by RAS

8/22/23 SVET

MTS reported for 6 months of 2023 by IFRS

8/22/23 MTSS

Kamaz invested in the startup of JSC National Carrier

8/22/23 KMAZ